Wireless lung sensor could keep heart failure patients out of hospital

NCT ID NCT03375710

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a device called the Cordella™ Heart Failure System in 15 people with advanced heart failure. The system includes a small sensor implanted in the lung artery that measures pressure, sending data to doctors remotely. The goal was to see if it is safe and accurate, potentially allowing earlier treatment adjustments and fewer hospital visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cordella™ Heart Failure System (a home monitoring device with a pulmonary artery pressure sensor implant)
What this could lead to
If successful, this system could help doctors manage heart failure remotely, potentially reducing hospital stays and improving quality of life for patients.
What could go wrong
This was a small, early feasibility study with only 15 participants, so results may not apply to all patients. The device requires an implant, which carries risks like infection or sensor failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS III are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Galway University Hospital

    Galway, H91 YR71, Ireland

  • Ziekenhuis Oost Limburg

    Genk, 3600, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.